Cargando…

GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism

BACKGROUND: Glucocorticoid-remediable aldosteronism (GRA) is a form of heritable hypertension caused by a chimeric fusion resulting from unequal crossing over between 11β‐hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2), which are two genes with similar sequences. Different crossover pattern...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-Ching, Chen, Chia-I, Chen, Peng-Ying, Kuo, Chun-Hung, Hung, Yi-Hsuan, Peng, Kang-Yung, Wu, Vin-Cent, Tsai-Wu, Jyy-Jih, Hsu, Chia-Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750845/
https://www.ncbi.nlm.nih.gov/pubmed/35012455
http://dx.doi.org/10.1186/s12859-022-04561-w
_version_ 1784631553113980928
author Wu, Yu-Ching
Chen, Chia-I
Chen, Peng-Ying
Kuo, Chun-Hung
Hung, Yi-Hsuan
Peng, Kang-Yung
Wu, Vin-Cent
Tsai-Wu, Jyy-Jih
Hsu, Chia-Lang
author_facet Wu, Yu-Ching
Chen, Chia-I
Chen, Peng-Ying
Kuo, Chun-Hung
Hung, Yi-Hsuan
Peng, Kang-Yung
Wu, Vin-Cent
Tsai-Wu, Jyy-Jih
Hsu, Chia-Lang
author_sort Wu, Yu-Ching
collection PubMed
description BACKGROUND: Glucocorticoid-remediable aldosteronism (GRA) is a form of heritable hypertension caused by a chimeric fusion resulting from unequal crossing over between 11β‐hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2), which are two genes with similar sequences. Different crossover patterns of the CYP11B1 and CYP11B2 chimeric genes may be associated with a variety of clinical presentations. It is therefore necessary to develop an efficient approach for identifying the differences between the hybrid genes of a patient with GRA. RESULTS: We developed a long-read analysis pipeline named GRAde (GRA deciphering), which utilizes the nonidentical bases in the CYP11B1 and CYP11B2 genomic sequences to identify and visualize the chimeric form. We sequenced the polymerase chain reaction (PCR) products of the CYP11B1/CYP11B2 chimeric gene from 36 patients with GRA using the Nanopore MinION device and analyzed the sequences using GRAde. Crossover events were identified for 30 out of the 36 samples. The crossover sites appeared in the region exhibiting high sequence similarity between CYP11B1 and CYP11B2, and 53.3% of the cases were identified as having a gene conversion in intron 2. More importantly, there were six cases for whom the PCR products indicated a chimeric gene, but the GRAde results revealed no crossover pattern. The crossover regions were further verified by Sanger sequencing analysis. CONCLUSIONS: PCR-based target enrichment followed by long-read sequencing is an efficient and precise approach to dissecting complex genomic regions, such as those involved in GRA mutations, which could be directly applied to clinical diagnosis. The scripts of GRAde are available at https://github.com/hsu-binfo/GRAde. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04561-w.
format Online
Article
Text
id pubmed-8750845
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87508452022-01-11 GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism Wu, Yu-Ching Chen, Chia-I Chen, Peng-Ying Kuo, Chun-Hung Hung, Yi-Hsuan Peng, Kang-Yung Wu, Vin-Cent Tsai-Wu, Jyy-Jih Hsu, Chia-Lang BMC Bioinformatics Methodology BACKGROUND: Glucocorticoid-remediable aldosteronism (GRA) is a form of heritable hypertension caused by a chimeric fusion resulting from unequal crossing over between 11β‐hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2), which are two genes with similar sequences. Different crossover patterns of the CYP11B1 and CYP11B2 chimeric genes may be associated with a variety of clinical presentations. It is therefore necessary to develop an efficient approach for identifying the differences between the hybrid genes of a patient with GRA. RESULTS: We developed a long-read analysis pipeline named GRAde (GRA deciphering), which utilizes the nonidentical bases in the CYP11B1 and CYP11B2 genomic sequences to identify and visualize the chimeric form. We sequenced the polymerase chain reaction (PCR) products of the CYP11B1/CYP11B2 chimeric gene from 36 patients with GRA using the Nanopore MinION device and analyzed the sequences using GRAde. Crossover events were identified for 30 out of the 36 samples. The crossover sites appeared in the region exhibiting high sequence similarity between CYP11B1 and CYP11B2, and 53.3% of the cases were identified as having a gene conversion in intron 2. More importantly, there were six cases for whom the PCR products indicated a chimeric gene, but the GRAde results revealed no crossover pattern. The crossover regions were further verified by Sanger sequencing analysis. CONCLUSIONS: PCR-based target enrichment followed by long-read sequencing is an efficient and precise approach to dissecting complex genomic regions, such as those involved in GRA mutations, which could be directly applied to clinical diagnosis. The scripts of GRAde are available at https://github.com/hsu-binfo/GRAde. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04561-w. BioMed Central 2022-01-10 /pmc/articles/PMC8750845/ /pubmed/35012455 http://dx.doi.org/10.1186/s12859-022-04561-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Methodology
Wu, Yu-Ching
Chen, Chia-I
Chen, Peng-Ying
Kuo, Chun-Hung
Hung, Yi-Hsuan
Peng, Kang-Yung
Wu, Vin-Cent
Tsai-Wu, Jyy-Jih
Hsu, Chia-Lang
GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
title GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
title_full GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
title_fullStr GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
title_full_unstemmed GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
title_short GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
title_sort grade: a long-read sequencing approach to efficiently identifying the cyp11b1/cyp11b2 chimeric form in patients with glucocorticoid-remediable aldosteronism
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750845/
https://www.ncbi.nlm.nih.gov/pubmed/35012455
http://dx.doi.org/10.1186/s12859-022-04561-w
work_keys_str_mv AT wuyuching gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT chenchiai gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT chenpengying gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT kuochunhung gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT hungyihsuan gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT pengkangyung gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT wuvincent gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT tsaiwujyyjih gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT hsuchialang gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism
AT gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism